CERS Cerus Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CERS

Price (delayed)

$1.78

Market cap

$322.53M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.27

Enterprise value

$398.29M

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies ...

Highlights
The gross margin rose by 4.8% year-on-year
The company's gross profit rose by 3.5% YoY
The company's net income fell by 30% YoY but it rose by 2.4% QoQ
CERS's EPS is down by 23% year-on-year but it is up by 3.6% since the previous quarter
CERS's equity is down by 34% year-on-year and by 5% since the previous quarter
The quick ratio has declined by 9% since the previous quarter and by 7% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.cerus.com
Peers: HAE UTMD BSX BIOL

Key stats

What are the main financial stats of CERS
Market
Shares outstanding
181.2M
Market cap
$322.53M
Enterprise value
$398.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.68
Price to sales (P/S)
1.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.16
Earnings
Revenue
$184.78M
EBIT
-$41.41M
EBITDA
-$36.7M
Free cash flow
-$35.58M
Per share
EPS
-$0.27
Free cash flow per share
-$0.2
Book value per share
$0.27
Revenue per share
$1.02
TBVPS
$1.13
Balance sheet
Total assets
$205.84M
Total liabilities
$156.82M
Debt
$94.92M
Equity
$48.17M
Working capital
$70.81M
Liquidity
Debt to equity
1.97
Current ratio
1.88
Quick ratio
1.31
Net debt/EBITDA
-2.06
Margins
EBITDA margin
-19.9%
Gross margin
62.8%
Net margin
-26.9%
Operating margin
-22.2%
Efficiency
Return on assets
-23.9%
Return on equity
-88.4%
Return on invested capital
-22.7%
Return on capital employed
-32.9%
Return on sales
-22.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CERS stock price

How has the Cerus stock price performed over time
Intraday
5.95%
1 week
7.88%
1 month
40.16%
1 year
-51.23%
YTD
-51.23%
QTD
9.88%

Financial performance

How have Cerus's revenue and profit performed over time
Revenue
$184.78M
Gross profit
$116.12M
Operating income
-$40.98M
Net income
-$49.79M
Gross margin
62.8%
Net margin
-26.9%
Cerus's operating margin has decreased by 34% YoY but it has increased by 6% QoQ
CERS's operating income is down by 32% year-on-year but it is up by 5% since the previous quarter
Cerus's net margin has decreased by 31% YoY but it has increased by 2.9% QoQ
The company's net income fell by 30% YoY but it rose by 2.4% QoQ

Growth

What is Cerus's growth rate over time

Valuation

What is Cerus stock price valuation
P/E
N/A
P/B
6.68
P/S
1.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.16
CERS's EPS is down by 23% year-on-year but it is up by 3.6% since the previous quarter
CERS's price to book (P/B) is 39% lower than its 5-year quarterly average of 10.4 and 25% lower than its last 4 quarters average of 8.4
CERS's equity is down by 34% year-on-year and by 5% since the previous quarter
The stock's price to sales (P/S) is 76% less than its 5-year quarterly average of 6.8 and 37% less than its last 4 quarters average of 2.6

Efficiency

How efficient is Cerus business performance
CERS's return on equity has dropped by 81% year-on-year and by 8% since the previous quarter
Cerus's return on assets has decreased by 39% YoY
The ROIC has contracted by 33% YoY but it has grown by 8% from the previous quarter
CERS's return on sales is down by 29% year-on-year but it is up by 5% since the previous quarter

Dividends

What is CERS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CERS.

Financial health

How did Cerus financials performed over time
CERS's total assets is 31% greater than its total liabilities
Cerus's total liabilities has increased by 11% YoY and by 7% QoQ
The quick ratio has declined by 9% since the previous quarter and by 7% year-on-year
Cerus's debt is 97% higher than its equity
Cerus's debt to equity has surged by 64% YoY and by 14% QoQ
CERS's equity is down by 34% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.